Startup Focuses on Drug That Prevents Iron Absorption Into the Body
from The University of Kansas
Bond Biosciences, a new startup based on research done at the University of Kansas, focuses on a new treatment for patients whose bodies absorb too much iron from the food they eat. The new technology is from the lab of Cory Berkland, a KU distinguished professor with dual appointments in pharmaceutical chemistry and chemical and petroleum engineering. His research focuses on ways to more effectively deliver drugs to their intended treatment targets in the body.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063